Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)

GSK Investigational Site, Alken

GSK Investigational Site, Liège

GSK Investigational Site, Córdoba

GSK Investigational Site, Mont-Godinne

GSK Investigational Site, Kortrijk

GSK Investigational Site, Berlin

GSK Investigational Site, Milan

GSK Investigational Site, Achim

GSK Investigational Site, Oviedo

GSK Investigational Site, Hüttenberg

GSK Investigational Site, Bologna

GSK Investigational Site, Bochum

GSK Investigational Site, Bochum

GSK Investigational Site, Hattingen

GSK Investigational Site, Pisa

GSK Investigational Site, Guardiagrele (CH)

GSK Investigational Site, Ellwangen

GSK Investigational Site, Würzburg

GSK Investigational Site, Providencia / Santiago

GSK Investigational Site, Santiago

GSK Investigational Site, Santiago

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Buenos Aires

GSK Investigational Site, Santiago

GSK Investigational Site, San José

GSK Investigational Site, San José

GSK Investigational Site, Dresden

GSK Investigational Site, Lima

GSK Investigational Site, Bialystok

GSK Investigational Site, Chełmno

GSK Investigational Site, Kościan

GSK Investigational Site, Bratislava

GSK Investigational Site, Bratislava

GSK Investigational Site, Levoča

GSK Investigational Site, Liptovský Mikuláš

GSK Investigational Site, Rimavská Sobota

GSK Investigational Site, Trenčín

GSK Investigational Site, Solna